Neurosensory Disorders Center

234 Goodman Street, Cincinnati, Ohio 45219 | (866) 941-UCNI (8264)

UC Is One of 15 Sites in National Hybrid Cochlear Implant Trial

 
 

Tuesday, October 12, 2010
Contact: 
Katie Pence
(513) 558-4561
katie.pence@uc.edu

CINCINNATI—Researchers with the University of Cincinnati’s Department of Otolaryngology-Head and Neck Surgery are participating in a national trial to study a new device that combines two types of existing hearing-loss technology.

The device, a Hybrid L 24 cochlear implant manufactured by Cochlear Americas, combines the external amplification technology of a hearing aid with the internal processor of a traditional cochlear implant. A small, specialized electrode in the implant is designed to target and stimulate the high-frequency area of the cochlea.

Read more »
 

* * *

The UC Neuroscience Institute, a regional center of excellence, is dedicated to patient care, research, education, and the development of new treatments for stroke, brain and spinal tumors, epilepsy, traumatic brain and spinal injury, Alzheimer’s disease, Parkinson’s disease, neuromuscular disorders, multiple sclerosis, disorders of the senses (swallowing, voice, hearing, pain, taste and smell), and psychiatric conditions (bipolar disorder, schizophrenia, and depression).